| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 10/08/2009 | US20090252676 N-alkoxyamide conjugates as imaging agents |
| 10/08/2009 | US20090252675 Radionuclide Therapy for Urinary Bladder Cancer |
| 10/08/2009 | US20090252674 Tripodal Ligands with the Coordinating Motifs K2 -BH2 or K3 -BH3 Relevant for Biomedical Applications of Organometallic Complexes |
| 10/08/2009 | US20090252673 Methods of Making and Using Rubidium-81-Containing Compositions |
| 10/08/2009 | US20090252672 Nasal delivery of therapeutic agents using tight junction agonists |
| 10/07/2009 | EP2106804A2 Composition and method for detection of pre-metastatic sites |
| 10/07/2009 | EP2106442A1 Cancerous disease modifying antibodies |
| 10/07/2009 | EP2106441A1 Cancerous disease modifying antibodies |
| 10/07/2009 | EP0907735B2 Modulators of tissue regeneration |
| 10/07/2009 | CN101553259A Cytotoxicity mediation of cells evidencing surface expression of CD63 |
| 10/06/2009 | US7598246 A conjugated drug WITH ANTIBIOTIC, NUCLEOSIDE, ANTISENSE NUCLEIC ACID AND anti-cancer DRUGS CAPABLE OF RELEASING ANTIBIOTIC OR CYTOTOXIC COMPONENT UPON BINDING WITH BONE TISSUE; tissue-targeted therapy TREATING BONE CANCER AND INFECTION |
| 10/06/2009 | US7597876 Use in positron emission tomography for example or tissue targeted therapy; forming a F18 metal complex, and attaching the F-18 metal complex to the molecule such as peptide or antibody; improved biological half life |
| 10/06/2009 | US7597875 Diaminedioxime radiometal complexes |
| 10/01/2009 | WO2009117804A1 An anti-cancer cytotoxic monoclonal antibody |
| 10/01/2009 | WO2009071444A9 Novel imaging method |
| 10/01/2009 | WO2009000777A4 Imaging diagnostics by combining contrast agents |
| 10/01/2009 | US20090247509 for treating central nervous system disorders such as psychological disorders, drug dependence and abuse, dyskinesia, dementia, anxiety disorders, sleep disorders and mood disorders |
| 10/01/2009 | US20090246214 Fusion proteins containing recombinant cytotoxic rnases |
| 10/01/2009 | US20090246133 Methods and compositions related to internalizing rgd peptides |
| 10/01/2009 | US20090246132 Epitope bound by MAbs A, B, C or D, where MAbs A, B, C and D have given variable domains; chimeric or humanized for side effect reduction; polymerase chain reaction |
| 10/01/2009 | US20090246131 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies |
| 10/01/2009 | US20090246130 Methods and Compositions for F-18 Labeling of Proteins, Peptides and Other Molecules |
| 10/01/2009 | US20090246129 Compositions and methods for the diagnosis and treatment of tumor |
| 10/01/2009 | US20090246128 Composition and method for detection of pre-metastatic sites |
| 10/01/2009 | US20090246127 Targeting agents for molecular imaging |
| 10/01/2009 | US20090246126 Thulium-based capsule and devices for use in high dose rate brachytherapy |
| 10/01/2009 | US20090246125 Magnetic resonance contrast media |
| 10/01/2009 | US20090246124 High affinity vegf-receptor antagonists |
| 10/01/2009 | US20090246123 Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin |
| 10/01/2009 | CA2712535A1 An anti-cancer cytotoxic monoclonal antibody |
| 09/30/2009 | EP2105136A2 Pharmaceutical compositions for treating cancer |
| 09/30/2009 | EP2105135A2 Pharmaceutical compositions for treating cancer |
| 09/30/2009 | EP2104732A1 Cancerous disease modifying antibodies |
| 09/30/2009 | EP1453525B1 Selective targeting of apoptotic cells |
| 09/30/2009 | EP1309627B1 Immunotherapy for chronic myelocytic leukemia with naked anti-nca-90 antibody |
| 09/30/2009 | CN101547707A Aurone derivative-containing composition for diagnosis |
| 09/30/2009 | CN101544584A Method for preparing precursor of Alzheimer disease imaging agent |
| 09/29/2009 | CA2378096C Kit for the preparation of technetium tc99m teboroxime myocardial perfusion agent |
| 09/29/2009 | CA2319443C Collagenous biomaterials formed with submucosal tissue |
| 09/24/2009 | US20090240041 Tumor imaging compounds |
| 09/24/2009 | US20090239837 Cholesterol-producing yeast strains and uses thereof |
| 09/24/2009 | US20090238760 Antispermatogenic, spermicidal and/or antifungal composition and methods of using the same |
| 09/24/2009 | US20090238759 Method of Rapid Methylation of Alkene Compound and Kit for PET Tracer Preparation Using the Same |
| 09/24/2009 | US20090238758 Random and non-random alkylene oxide polymer alloy compositions |
| 09/24/2009 | US20090238757 Methods and Compositions for Administering Therapeutic and Diagnostic Agents |
| 09/24/2009 | US20090238756 Image-guided therapy of myocardial disease: composition, manufacturing and applications |
| 09/24/2009 | US20090238755 Use of antibodies or binding portions thereof, probes, ligands, or other biological agents which either recognize an extracellular domain of prostate specific membrane antigen or bind to and are internalized with prostate specific membrane antigen |
| 09/24/2009 | US20090238754 Use of pyrene to carry peptides across the blood brain barrier |
| 09/23/2009 | EP2101826A2 Radiolabelled peptide based compounds and uses thereof |
| 09/23/2009 | EP2101818A1 Binding agents to the integrin alpha-11 subunit, and uses thereof |
| 09/23/2009 | EP0863981B1 Detection, prevention and treatment of papillomatous digital dermatitis |
| 09/23/2009 | CN101538313A Peptide-based compounds |
| 09/23/2009 | CN101538284A Preparation method and application of 99Tcm-EDTA-MTI coordination compound |
| 09/23/2009 | CN101538249A Preparation method of tritium or deuterium-labeled cyadox |
| 09/23/2009 | CN101537193A Vesicle monoamine transporter target bound drug and preparation method thereof |
| 09/23/2009 | CN101537190A Peptide-based compounds |
| 09/23/2009 | CN100542612C Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 09/22/2009 | US7591995 Cobalamin conjugates useful as imaging and therapeutic agents |
| 09/22/2009 | US7591993 Microspheres useful for embolization which comprises polyvinylalcohol. The present invention also relates to an injectable suspension suitable for embolization which comprises the polyvinylalcohol microspheres and a suitable |
| 09/22/2009 | US7591953 Methods and apparatus for continuous large-scale radiolabeling of proteins |
| 09/22/2009 | CA2360419C Molecules for the treatment and diagnosis of tumours |
| 09/22/2009 | CA2333086C Cocaine receptor binding ligands |
| 09/22/2009 | CA2278586C Coated implantable medical device |
| 09/17/2009 | WO2009114776A2 Integrin targeting agents and methods of using same |
| 09/17/2009 | WO2009114549A2 99mtc-labeled 19 amino acid containing peptide for use as phosphatidylethanolamine binding molecular probe and radiopharmaceutical |
| 09/17/2009 | WO2009112823A2 Metal complexes |
| 09/17/2009 | WO2009112488A2 Polyether polyol dendron conjugates with effector molecules for biological targeting |
| 09/17/2009 | WO2009073273A3 Perfluoro-aryliodonium salts in nucleophilic aromatic 18f-fluorination |
| 09/17/2009 | WO2009037336A3 Improved radiopharmaceutical composition |
| 09/17/2009 | US20090232735 Use of fructose-based therapies for the treatment of cancer |
| 09/17/2009 | US20090232734 Anti-tissue factor antibodies and compositions |
| 09/17/2009 | US20090232733 Diagnostic and Therapeutic Potential of Immune Globulin Intravenous (IGIV) Products |
| 09/17/2009 | US20090232732 PRO108 Antibody Compositions and Methods of Use and Use of PRO108 to Assess Cancer Risk |
| 09/17/2009 | US20090232731 Cationic Liposomal Preparations for the Treatment of Rheumatoid Arthritis |
| 09/17/2009 | US20090232730 Method of producing immunoliposomes and compositions thereof |
| 09/17/2009 | CA2724462A1 99mtc-labeled 19 amino acid containing peptide for use as phosphatidylethanolamine binding molecular probe and radiopharmaceutical |
| 09/17/2009 | CA2718363A1 Metal complexes |
| 09/17/2009 | CA2718244A1 Polyether polyol dendron conjugates with effector molecules for biological targeting |
| 09/17/2009 | CA2715034A1 Integrin targeting agents and in-vivo and in-vitro imaging methods using the same |
| 09/16/2009 | EP2100900A1 Bombesin analog peptide antagonist conjugates |
| 09/16/2009 | EP2100621A1 Polyether polyol dendron conjugates with effector molecules for biological targeting |
| 09/16/2009 | EP2099823A2 Variant target binding agents and uses thereof |
| 09/16/2009 | EP2099499A2 Synthesis of a radiofluorinated peptide using microwave activation technology |
| 09/16/2009 | EP2099304A2 Carboranylporphyrins and uses thereof |
| 09/16/2009 | EP1517919B9 Marked peptides having affinity for a phospholipid and uses |
| 09/16/2009 | EP0975595B9 Analogs of cocaine |
| 09/16/2009 | CN101534867A Compounds and methods for 18f labeled agents |
| 09/16/2009 | CN101534866A A system for determining a distribution of radioactive agents in a subject |
| 09/16/2009 | CN101534865A Methods and compositions for generating bioactive assemblies of increased complexity and uses |
| 09/16/2009 | CN101531706A Tumor vascular targeting peptide GX1 |
| 09/16/2009 | CN101531704A Peptide-based compounds |
| 09/16/2009 | CN100540053C New clinical parameters for determining hematologic toxicity proior to radioimmunotherapy |
| 09/15/2009 | US7589180 Specific binding proteins and uses thereof |
| 09/15/2009 | US7589061 Tc and Re labeler radioactive glycosylated octreotide derivatives |
| 09/15/2009 | US7588760 Binds to a denatured collagens but not to native triple helical forms of the collagen; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists |
| 09/15/2009 | CA2522563C Methods of producing carbon-13 labeled biomass |
| 09/15/2009 | CA2440372C Preparation for determining pyrimidine metabolic capacity |
| 09/15/2009 | CA2379696C Inhibition of renal uptake of radiomolecules with a combination of lysine and arginine |
| 09/15/2009 | CA2366514C Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 09/11/2009 | WO2009111273A2 Peptide targeting imaging agents and methods of use thereof |